Company Filing History:
9 out of 1,384 
2 out of 517 
Years Active: 2014-2025
Title: Mark Feinberg: Innovator in Cancer Immunotherapy
Introduction
Mark Feinberg is a notable inventor based in Newton, MA (US), recognized for his contributions to the field of cancer immunotherapy. With a total of nine patents to his name, Feinberg has made significant strides in the modulation of T regulatory cells, which play a crucial role in the immune response.
Latest Patents
Feinberg's latest patents include innovative methods for the use of small molecule inhibitors to Krüppel-like Factor 10 (KLF10). These inventions focus on compositions and methods for inhibiting KLF10 to modulate T regulatory cells and enhance cancer immunotherapy. This groundbreaking work aims to improve therapeutic outcomes for cancer patients.
Career Highlights
Throughout his career, Feinberg has worked with prestigious institutions such as Brigham and Women's Hospital, Inc. and Beth Israel Deaconess Medical Center, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research.
Collaborations
Feinberg has collaborated with notable colleagues, including Xinghui Sun and Akm Khyrul Wara. These partnerships have further enriched his research and development efforts in cancer treatment.
Conclusion
Mark Feinberg's innovative work in cancer immunotherapy and his numerous patents highlight his significant impact on the field. His dedication to advancing medical science continues to inspire future research and development in cancer treatment.